Liv Labs
Liv Labs, based in Chicago and offering remote work, develops innovative healthcare solutions targeting the $8B incontinence market, including a novel continence pessary and adaptive health coaching software.
Company Overview
Liv Labs, formerly known as Liv Labs Inc., operates in the healthcare industry, specifically targeting the consumer health and wellness sub-sector. The company, founded in 2021, develops modern solutions for incontinence. It operates out of Chicago, IL, with additional remote work options, and serves regions including the United States, America/Canada, and fully remote areas. Liv Labs participated in the Y Combinator S21 batch.
Incontinence Solutions
Liv Labs is focused on addressing the $8 billion market for incontinence solutions. The company is developing innovative products, including adaptive health coaching software and a novel continence pessary. These solutions are designed to provide effective and modern care for those dealing with incontinence.
Clinical Trials and Research
Liv Labs has initiated an FDA-reviewed clinical trial at Northwestern University. Additional clinical trials are being conducted at Ohio State University (OSU) and the University of Alabama at Birmingham (UAB). These trials aim to validate the efficacy and safety of their developed solutions in real-world settings.
Funding and Patents
Liv Labs has raised $2.6 million in funding, which includes grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF). The company holds utility patents in the US, Europe, and Hong Kong, with an additional patent pending in Australia. These financial and intellectual property resources support the development and commercialization of their innovative health solutions.